No abstract available
Keywords:
AHA Scientific Statements; P2Y12 inhibitor; acute coronary syndrome; aspirin; coronary artery disease; coronary stents; dual antiplatelet therapy (DAPT); focused update; stable ischemic heart disease.
MeSH terms
-
Acute Coronary Syndrome / diagnosis
-
Acute Coronary Syndrome / epidemiology
-
Acute Coronary Syndrome / therapy
-
Advisory Committees / standards
-
American Heart Association*
-
Cardiology / standards*
-
Coronary Artery Bypass / methods
-
Coronary Artery Bypass / standards
-
Coronary Artery Disease / diagnosis
-
Coronary Artery Disease / epidemiology
-
Coronary Artery Disease / therapy*
-
Disease Management
-
Humans
-
Myocardial Infarction / diagnosis
-
Myocardial Infarction / epidemiology
-
Myocardial Infarction / therapy
-
Myocardial Ischemia / diagnosis
-
Myocardial Ischemia / epidemiology
-
Myocardial Ischemia / therapy
-
Percutaneous Coronary Intervention / methods
-
Percutaneous Coronary Intervention / standards
-
Perioperative Care / methods
-
Perioperative Care / standards*
-
Platelet Aggregation Inhibitors / therapeutic use
-
Practice Guidelines as Topic / standards*
-
Research Report / standards
-
Societies, Medical / standards*
-
United States / epidemiology
Substances
-
Platelet Aggregation Inhibitors